ConductScience.org, home

Paper2003990

Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.

Raina V and 3 others. Br J Cancer, 1991. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Papers, record 2003990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2003990

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.
PubMed
Journal
Br J Cancer
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raina VV
2Cunningham DD
3Gilchrist NN
4Soukop MM

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
Lymphoma, FollicularMajor topic
Calcitriol
Calcium
Female
Humans
Male

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,895,8621,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.Cancer Res1982https://conductscience.org/library/papers/6895862PubMed
26,277,475Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.Cancer Res1982https://conductscience.org/library/papers/6277475PubMed
36,427,9261,25-dihydroxyvitamin D3: a novel immunoregulatory hormone.Science1984https://conductscience.org/library/papers/6427926PubMed
46,611,3551 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.J Clin Invest1984https://conductscience.org/library/papers/6611355PubMed
56,548,796The natural history of initially untreated low-grade non-Hodgkin's lymphomas.N Engl J Med1984https://conductscience.org/library/papers/6548796PubMed
62,996,693Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/2996693PubMed
73,754,6001,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20).J Steroid Biochem1986https://conductscience.org/library/papers/3754600PubMed
83,024,816Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.Cancer Res1987https://conductscience.org/library/papers/3024816PubMed
93,027,709Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3027709PubMed
103,110,950Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.Science1987https://conductscience.org/library/papers/3110950PubMed
112,829,219Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2829219PubMed
121,089,470Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.Cancer1975https://conductscience.org/library/papers/1089470PubMed
131,030,780Spontaneous regression of hematologic cancers.Natl Cancer Inst Monogr1976https://conductscience.org/library/papers/1030780PubMed
147,459,811Reporting results of cancer treatment.Cancer1981https://conductscience.org/library/papers/7459811PubMed
156,257,4951,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.Endocrinology1981https://conductscience.org/library/papers/6257495PubMed
166,310,7481,25-dihydroxyvitamin D3 receptors in human leukocytes.Science1983https://conductscience.org/library/papers/6310748PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
39,677,358Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial.EClinicalMedicine2024https://conductscience.org/library/papers/39677358PubMed
24,772,087The future of vitamin D analogs.Front Physiol2014https://conductscience.org/library/papers/24772087PubMed
21,119,732Vitamin D, disease and therapeutic opportunities.Nat Rev Drug Discov2010https://conductscience.org/library/papers/21119732PubMed
21,048,153Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.Blood2011https://conductscience.org/library/papers/21048153PubMed
20,713,849Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.J Clin Oncol2010https://conductscience.org/library/papers/20713849PubMed
20,562,184Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Am J Epidemiol2010https://conductscience.org/library/papers/20562184PubMed
20,373,010A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults.Cancer Causes Control2010https://conductscience.org/library/papers/20373010PubMed
19,832,043Vitamin D and non-Hodgkin lymphoma risk in adults: a review.Cancer Invest2009https://conductscience.org/library/papers/19832043PubMed
19,035,445A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.Int J Cancer2009https://conductscience.org/library/papers/19035445PubMed
14,586,212Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.Invest New Drugs2003https://conductscience.org/library/papers/14586212PubMed
8,912,548Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.Br J Cancer1996https://conductscience.org/library/papers/8912548PubMed
8,398,690The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.Br J Cancer1993https://conductscience.org/library/papers/8398690PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2003990

GET https://conductscience.org/api/papers/v1/2003990/authors